Ricardo Correa MD, EdD, FACP, FACE, FAPCR, FACMQ
@drricardocorrea
Endocrinologist, methodologist , medical educator, IMG, passion for helping others, changing medicine, advocate for patient and physician, clinical epidemiology
ID: 62438316
03-08-2009 04:42:04
3,3K Tweet
3,3K Followers
2,2K Following
Truly grateful for the opportunity to discuss the CATALYST trial with an exceptional team. Cleveland Clinic
If you are a fan of GLP-1/GIP RA like me - come check out this rare but serious side effect! We’re presenting a case of tirzepatide- associated interstitial kidney injury ENDO 2025 | Poster Board 520 | 12:15 PM #ENDO2025 Endocrine Society
MACS is more common than we think and we keep missing it. Our poster looks at the incidence and clinical features of MACS in a large referral center. 📍ENDO 2025 Ricardo Correa MD, EdD, FACP, FACE, FAPCR, FACMQ Recordati Rare Diseases Endocrine Society #ENDO2025 #MACS #adrenal
Thanks Telemundo for the interview on the use of CGM in patients with no diabetes Cleveland Clinic AMA ACP Arizona Medical Association (ArMA) Endocrine Today Endocrine Society AACE
🔥🔥 Hot off the press! The August issue of Endocrine Today is now live! Don't miss this month's #HealioExclusive, which takes a deep dive into the biggest news from #ADA2025. Read perspectives from Joshua Neumiller, Ricardo Correa MD, EdD, FACP, FACE, FAPCR, FACMQ and more! healio.com/news/endocrino…